Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 11/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.53 |
| ▸ | PPARD | Q03181 | 7/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9498760 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL9406944 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL10438736 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL9500437 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL5074106 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL9498754 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL23879500 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL22404400 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL22404039 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD | |
| SCHEMBL8981724 | 1.00 | GPR84 (0.67) | GPR84LMNAFFAR1FFAR4PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | GLYTECH, INC. (JP) | 2014-09-04 | — | — | US | disclosed |
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | GLYTECH, INC. (JP) | 2014-09-04 | — | — | US | disclosed |
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | GLYTECH, INC. (JP) | 2014-09-04 | — | — | US | disclosed |
| US-8741871-B2 | Trehalose compound, method for producing same, and pharmaceutical product containing the compound | GLYTECH, INC. (JP) | 2014-06-03 | — | — | US | disclosed |
| US-8741871-B2 | Trehalose compound, method for producing same, and pharmaceutical product containing the compound | GLYTECH, INC. (JP) | 2014-06-03 | — | — | US | disclosed |
| EP-2567963-A1 | Trehalose compound, method for producing same, and pharmaceutical product containing the compound | Otsuka Chemical Co., Ltd. (JP) | 2013-03-13 | — | — | EP | disclosed |
| CN-102203110-A | Trehalose compound, method for producing same, and pharmaceutical product containing the compound | OTSUKA CHEMICAL CO LTD | 2011-09-28 | — | — | CN | disclosed |
| US-20110218171-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-09-08 | — | — | US | disclosed |
| US-20110218171-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-09-08 | — | — | US | disclosed |
| EP-2351764-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | Otsuka Chemical Co., Ltd. (JP) | 2011-08-03 | — | — | EP | disclosed |
| EP-0651632-B2 | HAIR COSMETIC COMPOSITION | KAO CORP (JP) | 2008-04-16 | — | — | EP | disclosed |
| EP-0651632-B1 | HAIR COSMETIC COMPOSITION | KAO CORP (JP) | 1997-10-15 | — | — | EP | disclosed |
| US-5587155-A | COMPRISING A FATTY ACID, POLYHYDRIC ALCOHOL, AROMATIC ALCOHOL AND AT LEAST ONE QUATERNARY AMMONIUM COMPOUND; HAIR CONDITIONERS | KAO CORPORATION (JP) | 1996-12-24 | — | — | US | disclosed |
| EP-0651632-A1 | HAIR COSMETIC COMPOSITION. | KAO CORP (JP) | 1995-05-10 | — | — | EP | disclosed |
| US-5401604-A | Reaction product of polyepoxide, aromatic acid with phenolic hydroxy group, aromatic acid, quinone diazide with sulfonyl group, photoresists | NIPPON PAINT CO., LTD. (JP) | 1995-03-28 | — | — | US | disclosed |
| EP-0608894-A1 | Positive-type photosensitive resin compositions | Nippon Paint Co., Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |
| WO-1994002111-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218171-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | TREH, MAN2B1, NFATC1 | GPR84 3879/4885LMNA 1927/4885FFAR1 2167/4885 |
| US-20140248317-A1 | TREHALOSE COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | TREH, MAN2B1, NFATC1 | GPR84 3879/4885LMNA 1927/4885FFAR1 2167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.